Prevalence, species distribution and antifungal susceptibility of Candida albicans causing vaginal discharge among symptomatic non-pregnant women of reproductive age at a tertiary care hospital, Vietnam

• Published in: BMC infectious diseases Vol. 21; no. 1; pp. 1 - 523
• Main Authors: Anh, Do Ngoc, Hung, Dao Nguyen, Tien, Tran Viet, Dinh, Vu Nhat, Son, Vu Tung, Luong, Nguyen Viet, Van, Nguyen Thi, Quynh, Nguyen Thi Nhu, Van Tuan, Nguyen, Tuan, Le Quoc, Bac, Nguyen Duy, Luc, Nguyen Khac, Anh, Le Tran, Trung, Do Minh
• Format: Journal Article
• Language: English
• Published: London BioMed Central Ltd 03.06.2021; BioMed Central; BMC
• Subjects: Age; Antifungal agents; Antifungal susceptibility; Candida; Candida albicans; Candidiasis; Candidiasis, Vulvovaginal; Caspofungin; Causes of; Chloramphenicol; Chloromycetin; Colonization; Dextrose; Distribution; Enzymes; Epidemiology; Fluconazole; Flucytosine; Fungicides; Geographical distribution; Health aspects; Hormone replacement therapy; Identification and classification; Infections; Infectious diseases; Itraconazole; Laboratories; Micafungin; Miconazole; Pregnancy; Pregnant women; Prevalence; Reproductive age women; Species; Statistics; Susceptibility; Vagina; Vaginal diseases; Voriconazole; Vulvovaginal candidiasis; Womens health; Yeast; Yeasts; Vietnam; England; United Kingdom > UK; United States > US; Germany
• ISSN: 1471-2334; 1471-2334
• DOI: 10.1186/s12879-021-06192-7

Vaginal candidiasis is frequent in women of reproductive age. Accurate identification Candida provides helpful information for successful therapy and epidemiology study; however, there are very limited data from the Vietnam have been reported. This study was performed to determine the prevalence, species distribution of yeast causing vaginal discharge and antifungal susceptibility patterns of Candida albicans among symptomatic non-pregnant women of reproductive age. Vaginal discharge samples were collected from 462 women of reproductive age in Hanoi, Vietnam between Sep 2019 and Oct 2020. Vaginal swabs from these patients were examined by direct microscopic examination (10% KOH). CHROMagar[TM] Candida medium and Sabouraud dextrose agar supplemented with chloramphenicol (0.5 g/l) were used to isolate yeast, and species identification was performed using morphological tests and molecular tools (PCR and sequencing). Antifungal susceptibility testing was determined according to the Clinical and Laboratory Standards Institute guidelines (M27-A3 and M27-S4). The prevalence of vaginal yeast colonization in non-pregnant women was 51.3% of 462 participants. Nine different yeast species were identified. Among these isolates, C. albicans (51.37%) was the most frequent, followed by C. parapsilosis (25.88%), C. glabrata (11.37%), C. tropicalis (4.31%), C. krusei (3.92%), C. africana (1.57%), Saccharomyces cerevisiae (0.78%), C. nivariensis (1 isolates, 0.39%), and C. lusitaniae (1 isolates, 0.39%), respectively. Among C. albicans, all 46 isolates were 100% susceptible to micafungin, caspofungin, and miconazole. The susceptibility rates to amphotericine B, 5-flucytosine, fluconazole, itraconazole and voriconazole were 95.65, 91.30, 91.30, 82.61 and 86.95%, respectively. The prevalence of VVC among symptomatic non-pregnant women of reproductive age in Vietnam was higher than many parts of the world. The high frequency of non-albicans Candida species, which were often more resistant to antifungal agents, was a notable feature. Resistance rates of vaginal C. albicans isolates to antifungal agents was low. Our findings suggest that continued surveillance of changes in species distribution and susceptibility to antifungals should be routinely screened and treated.